New 'Trojan horse' antibiotic method promising in new randomized, double-blind clinical trial. The antibiotic, cefiderocol, binds to iron and the bacteria unknowingly transport it past their defences and inside their cells, as reported in the Lancet Infectious Diseases journal.

See the source article by following the link below:
New 'Trojan horse' antibiotic method promising in new randomized, double-blind clinical trial. The antibiotic, cefiderocol, binds to iron and the bacteria unknowingly transport it past their defences and inside their cells, as reported in the Lancet Infectious Diseases journal.